Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Non-Current Debt (2012 - 2015)

Dexcom (DXCM) reported Non-Current Debt of $400000.0 for Q3 2015, down 86.21% year-over-year from $2.9 million in Q3 2014, and down 63.64% on a QoQ basis from $1.1 million in Q2 2015.

Dexcom (DXCM) has 4 years of Non-Current Debt data on file, last reported at $400000.0 in Q3 2015.

  • Quarterly Non-Current Debt fell 86.21% year-over-year to $400000.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $400000.0 (down 86.21% YoY) and the FY2014 annual result came in at $2.3 million, down 50.0% from the prior year.
  • Non-Current Debt eased to $400000.0 in Q3 2015 per DXCM's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $6.8 million in Q4 2012 and bottomed at $400000.0 in Q3 2015.
  • The 4-year median for Non-Current Debt is $3.8 million (2014), against an average of $3.7 million.
  • The widest annual swing landed in 2013, when Non-Current Debt sank 32.35%; it then tumbled 86.21% in 2015.
  • Tracing DXCM's Non-Current Debt over 4 years: stood at $6.8 million in 2012, then slumped by 32.35% to $4.6 million in 2013, then tumbled by 50.0% to $2.3 million in 2014, then plunged by 82.61% to $400000.0 in 2015.
  • Per Business Quant, the three latest DXCM Non-Current Debt figures stand at $400000.0 (Q3 2015), $1.1 million (Q2 2015), and $1.7 million (Q1 2015).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 29.64 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.22 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 27.88 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 10.99 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 598.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.81 Bn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 6.30 Bn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2015 400,000.00
Sep 30, 2015 400,000.00
Jun 30, 2015 1.10 Mn
Jun 30, 2015 1.10 Mn
Mar 31, 2015 1.70 Mn
Mar 31, 2015 1.70 Mn
Dec 31, 2014 2.30 Mn
Dec 31, 2014 2.30 Mn
Sep 30, 2014 2.90 Mn
Sep 30, 2014 2.90 Mn
Jun 30, 2014 3.50 Mn
Jun 30, 2014 3.50 Mn
Mar 31, 2014 4.10 Mn
Mar 31, 2014 4.10 Mn
Dec 31, 2013 4.60 Mn
Dec 31, 2013 4.60 Mn
Sep 30, 2013 5.20 Mn
Sep 30, 2013 5.20 Mn
Jun 30, 2013 5.80 Mn
Jun 30, 2013 5.80 Mn
Mar 31, 2013 6.30 Mn
Mar 31, 2013 6.30 Mn
Dec 31, 2012 6.80 Mn
Dec 31, 2012 6.80 Mn